Aurenar's V-Link, a non-invasive nerve stimulation device for preventing brain hemorrhage complications, just won FDA breakthrough device designation after early trials showed it cut cerebral vasospasm by more than 40%.
Ear-based stimulation has the potential to provide health systems with a scalable, low-risk tool to address some of today’s most pressing challenges: rising rates of anxiety and depression, persistent post-viral syndromes and the long-term burden of stress-related chronic conditions.
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.
Innovations with vagus nerve stimulation are continuing to emerge, whether it be for treating tinnitus, stroke or chronic migraines.